Lilly Diabetes has been a global leader in diabetes care since 1923 when we introduced the world’s first commercial insulin. Ninety years later, we remain committed to meeting the needs of people with diabetes from medicines to support programs and more.
What Makes Us Unique
A major emphasis of our work is understanding that people with diabetes should first be seen as individuals. Many of our programs and solutions are designed based on feedback from people who live with the disease every day. We also understand that diabetes is bigger than any one company. Fighting the growing diabetes epidemic goes beyond the capabilities of any one entity or therapy. Lilly Diabetes’ donation of insulin vials to the Life for a Child program and our educational grant in support of the International Diabetes Federation's Bridges program—which supports translational research in local communities—represent just a few examples of our long-term commitment to diabetes care.
For more information, visit the Lilly Diabetes website.